PXYN.US Praxsyn Corp
- Market cap
- USD 6.35K
- P/E
- -
- P/B
- 0.72x
- ROE
- 107.6%
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2015.
Is PXYN.US undervalued?
Graham numberThe Graham number of Praxsyn Corp cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Praxsyn Corp fundamental analysis
No fundamental analysis for Praxsyn Corp yet.
Praxsyn Corp stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Praxsyn Corp
Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit-forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well…
Full company profilePraxsyn Corp financial statements
2015 annualized: Fiscal year 2015 is not finished. Income statement and cash flow are annualized from 3 quarters up to Sep 30, 2015, the balance sheet is the latest quarter. Figures change when the annual report is published.
Praxsyn Corp annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2011 | 2012 | 2013 | 2014 | 2015 Anlz |
|---|---|---|---|---|---|
| Income Statement | |||||
| Revenue | 1.58M | 0.00 | 6.99M | 66.6M | 69.7M |
| Gross Profit | -237K | 0.00 | 6.29M | 63.0M | 61.6M |
| Operating Income | -4.24M | -1.69M | 3.20M | 37.5M | 21.4M |
| Net Income | -7.51M | -1.22M | 230K | -12.4M | 9.23M |
| Balance Sheet | |||||
| Total Assets | 721K | 136K | 4.93M | 16.7M | 37.9M |
| Total Liabilities | 5.18M | 3.37M | 9.56M | 15.1M | 29.4M |
| Shareholders' Equity | -4.46M | -3.23M | -4.63M | 1.63M | 8.58M |
| Cash & Short-term Investments | 38.3K | 81.8K | 37.5K | 1.22M | 654K |
| Cash Flow | |||||
| Operating Cash Flow | -1.94M | -284K | -1.73M | -23.7M | -18.4M |
| Capital Expenditure | 87.7K | 4.00K | 4.00K | 67.7K | 369K |
| Ratios | |||||
| ROE | - | - | - | -757.1% | 107.6% |
| ROA | -1,042.8% | -897.9% | 4.7% | -74.0% | 24.3% |
| Net Profit Margin | -474.2% | - | 3.3% | -18.6% | 13.2% |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
Praxsyn Corp dividends
Praxsyn Corp has not paid dividends in the last 4 fiscal years.
Who owns Praxsyn Corp
Ownership data of Praxsyn Corp is not available yet.
Praxsyn Corp company profile
- Company name
- Praxsyn Corp
- Ticker
- PXYN.US
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Employees
- 66
- Fiscal year end
- December
- Address
- 7904 E Chaparral Rd STE A110-210, Scottsdale, AZ, United States, 85250
- Phone
- 949-777-6112
- Website
- praxsyn.com
About Praxsyn Corp
Praxsyn Corporation, a health care company, provides medical practitioners with medications and services for their patients. It formulates non-narcotic and non-habit-forming medications using therapeutic and preventative agents in the forms of transdermal creams, patches, and oral capsules for pain management, erectile dysfunction, and metabolic therapies. Praxsyn Corporation provides its products to patients covered under the California workers' compensation system, as well as preferred provider contracts. The company was formerly known as The PAWS Pet Company, Inc. and changed its name to Praxsyn Corporation in March 2014. Praxsyn Corporation was founded in 2005 and is headquartered in Scottsdale, Arizona.
Praxsyn Corp management
1- Sean DalyCEO & Director